More About Colin
Colin Rom is the public policy lead on the Bio + Health team, building a16z into a leading voice of health innovation in Washington, D.C.
Prior to joining Andreessen Horowitz, Colin was Managing Director of Science and Innovation Policy at Mayo Clinic, leading federal engagement strategy in areas of emerging biotechnology, care delivery, and artificial intelligence. Before Mayo, Colin spent two years as a policy advisor in the Commissioner’s Office at the U.S. Food and Drug Administration (FDA), leading several agency-wide initiatives and serving as a liaison between the FDA and Coronavirus Task Force during the first year of federal COVID-19 response. He also spent one year at the White House Office of Management and Budget and several years as a health policy advisor in the United States Senate, working for Senator Richard Burr (N.C.) and the Senate Committee on Health, Education, Labor, and Pensions.
Colin graduated from the University of Mary Washington and is currently pursuing his M.S. in Biotechnology Enterprise and Entrepreneurship from Johns Hopkins University. He is a native of Cary, North Carolina and enjoys golf and travel during his free time.
